Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2015 5
2016 1
2017 2
2018 4
2019 1
2020 1
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Identifying risk factors for COPD and adult-onset asthma: an umbrella review.
Holtjer JCS, Bloemsma LD, Beijers RJHCG, Cornelissen MEB, Hilvering B, Houweling L, Vermeulen RCH, Downward GS, Maitland-Van der Zee AH; P4O2 consortium. Holtjer JCS, et al. Among authors: hilvering b. Eur Respir Rev. 2023 May 3;32(168):230009. doi: 10.1183/16000617.0009-2023. Print 2023 Jun 30. Eur Respir Rev. 2023. PMID: 37137510 Free PMC article. Review.
Emerging Biologics in Severe Asthma.
Pavord ID, Hilvering B, Shrimanker R. Pavord ID, et al. Among authors: hilvering b. Immunol Allergy Clin North Am. 2016 Aug;36(3):609-23. doi: 10.1016/j.iac.2016.04.001. Immunol Allergy Clin North Am. 2016. PMID: 27401629 Review.
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making.
Otten J, van der Lans R, de Corso E, Dziadziulia K, Hilvering B, Weersink E, Bonini M, Hagemann J, Thaitrakool W, Montuori C, Klimek L, Reitsma S, Fokkens W. Otten J, et al. Among authors: hilvering b. Expert Rev Clin Immunol. 2023 Jul-Dec;19(8):1041-1049. doi: 10.1080/1744666X.2023.2218617. Epub 2023 May 29. Expert Rev Clin Immunol. 2023. PMID: 37226507
Multi-set Pre-processing of Multicolor Flow Cytometry Data.
Folcarelli R, Tinnevelt GH, Hilvering B, Wouters K, van Staveren S, Postma GJ, Vrisekoop N, Buydens LMC, Koenderman L, Jansen JJ. Folcarelli R, et al. Among authors: hilvering b. Sci Rep. 2020 Jun 16;10(1):9716. doi: 10.1038/s41598-020-66195-3. Sci Rep. 2020. PMID: 32546713 Free PMC article.
Clinical utility of asthma biomarkers: from bench to bedside.
Vijverberg SJ, Hilvering B, Raaijmakers JA, Lammers JW, Maitland-van der Zee AH, Koenderman L. Vijverberg SJ, et al. Among authors: hilvering b. Biologics. 2013;7:199-210. doi: 10.2147/BTT.S29976. Epub 2013 Aug 29. Biologics. 2013. PMID: 24009412 Free PMC article. Review.
Anti-IL-5/5Ra biologics improve work productivity and activity in severe asthma: a RAPSODI registry-based cohort study.
van der Valk JPM, Hekking PP, Rauh SP, Patberg KW, van Veen IA, Van Huisstede A, Smeenk FWJM, van de Ven MJT, Broeders MEAC, Hilvering B, van Exsel J, Oud KTM, Langeveld B, Fieten KB, van Veen A, Hashimoto S, Sont JK, Ten Brinke A, Braunstahl GJ; RAPSODI Team. van der Valk JPM, et al. Among authors: hilvering b. J Asthma. 2023 Oct;60(10):1869-1876. doi: 10.1080/02770903.2023.2196563. Epub 2023 Apr 21. J Asthma. 2023. PMID: 36976568
21 results